
---
title: Diuretics
markmap:
  colorFreezeLevel: 6
---

## Diuretics

- **Loop Diuretics**
  - Mechanism: Inhibit Na/K/2Cl cotransporter (NKCC2)
  - Site: Thick Ascending Limb (TAL) of Loop of Henle
  - Key Drugs: Furosemide, Bumetanide, Torsemide, Ethacrynic Acid (non-sulfa)
  - High-Yield Uses:
    - Edema (HF, Cirrhosis, Renal Failure)
    - Hypercalcemia
    - Hypertensive Crisis
  - Key Side Effects:
    - Ototoxicity (esp. Ethacrynic Acid)
    - Hypokalemia
    - Metabolic Alkalosis
    - Hypomagnesemia
    - Hypocalcemia
    - Sulfonamide Allergy (except Ethacrynic Acid)
    - Gout Exacerbation
- **Thiazide Diuretics**
  - Mechanism: Inhibit Na/Cl cotransporter (NCC)
  - Site: Distal Convoluted Tubule (DCT)
  - Key Drugs: Hydrochlorothiazide (HCTZ), Chlorthalidone (longer half-life), Indapamide, Metolazone (effective in CKD)
  - High-Yield Uses:
    - Hypertension (1st line for many)
    - Calcium Oxalate Stones (reduce urinary Ca)
    - Nephrogenic Diabetes Insipidus (Paradoxical effect)
    - Mild to moderate Edema
  - Key Side Effects:
    - HyperGLUC: HyperGlycemia, HyperLipidemia, HyperUricemia, HyperCalcemia
    - Hypokalemia
    - Metabolic Alkalosis
    - Hyponatremia
    - Sulfonamide Allergy
    - Gout Exacerbation
- **Potassium-Sparing Diuretics**
  - Site: Collecting Duct
  - Types & Mechanisms:
    - Aldosterone Antagonists: Block Aldosterone receptor
      - Drugs: Spironolactone, Eplerenone (more selective)
    - ENaC Inhibitors: Block Epithelial Sodium Channel (ENaC)
      - Drugs: Amiloride, Triamterene
  - High-Yield Uses:
    - Hyperaldosteronism (Primary & Secondary, eg. Cirrhosis, HF)
    - Heart Failure (Spironolactone/Eplerenone reduce mortality)
    - Prevent Hypokalemia (used with Loops/Thiazides)
    - Lithium-induced Nephrogenic DI (Amiloride)
  - Key Side Effects:
    - Hyperkalemia (Major concern)
    - Metabolic Acidosis (Aldosterone antagonists)
    - Gynecomastia & Antiandrogen effects (Spironolactone)
    - Kidney stones (Triamterene)
- **Carbonic Anhydrase Inhibitors (CAIs)**
  - Mechanism: Inhibit Carbonic Anhydrase -> block NaHCO3 reabsorption
  - Site: Proximal Convoluted Tubule (PCT) primarily
  - Key Drugs: Acetazolamide (systemic), Dorzolamide, Brinzolamide (topical for glaucoma)
  - High-Yield Uses:
    - Glaucoma (reduce aqueous humor)
    - Altitude Sickness
    - Metabolic Alkalosis
    - Pseudotumor Cerebri
  - Key Side Effects:
    - Metabolic Acidosis (Non-anion gap)
    - Hypokalemia
    - Renal Stones (alkaline urine)
    - Sulfonamide Allergy
    - Paresthesias
- **Osmotic Diuretics**
  - Mechanism: Increase osmolality of tubular fluid -> prevent water reabsorption
  - Site: PCT, Loop of Henle, Collecting Duct
  - Key Drugs: Mannitol, Urea
  - High-Yield Uses:
    - Cerebral Edema (reduce ICP)
    - Acute Angle Closure Glaucoma (reduce intraocular pressure)
    - Promote excretion of toxins (e.g., salicylates)
  - Key Side Effects:
    - Pulmonary Edema (Contraindicated in HF)
    - Dehydration
    - Electrolyte imbalances (Initial hyponatremia, later hypernatremia)
    - Headache, Nausea
- **INICET Buzz Words/Pearls**
  - **Ototoxicity:** Loops (Ethacrynic Acid > others)
  - **Hypercalcemia Treatment:** Loop Diuretics
  - **Hypocalcemia:** Thiazides cause hypercalcemia (opposite effect)
  - **Gout:** Thiazides > Loops (exacerbate)
  - **Nephrogenic DI:** Thiazides (Paradoxical Effect), Amiloride (Lithium-induced)
  - **Spironolactone:** Gynecomastia, Used in HF (mortality benefit)
  - **Metolazone:** Effective in CKD/Low GFR
  - **Acetazolamide:** Altitude Sickness, Glaucoma, Metabolic Acidosis
  - **Mannitol:** Cerebral Edema, Pulmonary Edema Risk, NOT for general edema
  - **Metabolic Alkalosis:** Loops, Thiazides (via volume contraction & K loss)
  - **Metabolic Acidosis:** CA Inhibitors, Aldosterone Antagonists (via K retention)
  - **Sulfonamide Allergy Risk:** Loops, Thiazides, CAIs (except Ethacrynic Acid)
  - **Potency:** Loop > Thiazide > K-Sparing / CAI
  - **Combined Use:** Loop/Thiazide + K-Sparing (prevent K loss)
